![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 30, 23139-23145, July 28, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Sung Ae Life Science Research Institute, Kyeonggi 423-030, South Korea and the
Received for publication, November 17, 1999, and in revised form, April 26, 2000
Disruption of the function of tumor suppressor
proteins occasionally can be dependent on their subcellular
localization. In about 40% of the breast cancer tissues, p53 is found
in the cytoplasm as opposed to the nucleus, where it resides in normal
breast cells. This means that the regulation of subcellular location of
p53 is an important mechanism in controlling its function. The
transport factors required for the nuclear export of p53 and the
mechanisms of their nuclear export have been extensively characterized.
However, little is known about the mechanism of nuclear import of p53. p53 contains putative nuclear localization signals (NLSs) which would
interact with a nuclear transport factor, importin p53 is a tumor suppressor gene and various
p53 gene mutations are found in over 50% of all human
cancers (1). Although inactivation of tumor suppressor proteins is
generally thought to originate in their genetic mutations, disruption
of their function can occasionally be independent of such mutations.
Moll et al. (2) have reported that about 37% out of 27 samples of breast cancer tissues showed cytoplasmic localization of
wild-type p53, resulting in inhibition of normal p53 function (2).
Nuclear exclusion of wild-type p53 has also been reported in
neuroblastoma and colon carcinoma cells (3, 4). In another study,
wild-type p53 was located in the cytoplasm of human cervical carcinoma
cell lines with integrated human papillomavirus-18 or -16 (5). In colon
carcinoma, cytoplasmic accumulation of p53 correlates with unfavorable
prognosis (4). These data indicate that the regulation of p53
subcellular location is an important mechanism in controlling p53 function.
In eukaryotic cells, the nucleus is separated from the cytoplasm by the
nuclear envelope. This spatial segregation requires a nuclear transport
system to correctly import or export nuclear components at the proper
time. The prototype of the nuclear transport signal is the classical
nuclear localization signal
(NLS),1 and nuclear import of
proteins bearing an NLS is dependent on two cellular factors termed
importin Since p53 functions as a transcriptional activator (1), p53 must enter
the cell nucleus where it can function as a transcription activator.
p53 has three potential nuclear localization signals in the C terminus
of the protein (1). The major one, PQPKKKP, is able to direct the
cytoplasmic protein to the nucleus (16). Although a set of transport
factors required for the nuclear export of p53 has been identified and
extensively characterized (17), the precise mechanism of the nuclear
import has not yet been elucidated in vivo.
Our work was initiated to study the mechanisms of importin Cell Culture--
Human breast cancer cell line ZR-75-1 was
grown in RPMI medium (Life Technologies) supplemented with 10%
heat-inactivated fetal bovine serum (Life Technologies) at 37 °C in
a humidified 5% CO2-containing atmosphere. HBL-100 (human
mammary epithelial cell) and CHO-K1 (Chinese hamster ovary cell line)
was grown in Dulbecco's modified Eagle's medium (Life Technologies)
containing 10% fetal bovine serum.
RT-PCR and Southern Blot--
Total cell RNA was isolated from
2 × 107 cells of ZR-75-1 cell line using
Catrimox-14TM surfactant solution (Iowa Biotechnology) as
described by the manufacturer. The Takara RNA LA PCR kit (Takara) was
used to RT-PCR with slight modification. In brief, 300 ng of total RNA
was used for cDNA synthesis using avian myeloblastosis reverse
transcriptase with oligo-d(T) adaptor primer and subsequent cDNA
amplification using Takara LA Taq with upstream primer
(5'-ATGTCCACCAACGAGAATGCTAATAC-3') and downstream primer
(5'-CTAAAAGTTAAAGGTCCCAGGAGCCCC-3') for importin Cloning and Sequencing Analysis--
The positive bands
identified by Southern blot analysis were isolated from agarose gel
using GENECLEAN kit (Bio-101), cloned to SmaI digested-pRIP
cloning vector (Bioneer), and subjected to sequencing using universal
primers. AccuPowerTM DNA sequencing kit and
SilverstarTM staining kit (Bioneer) were used for DNA sequencing.
NLS Mutagenesis--
Point mutation was constructed by a
PCR-based technique (18). For the p53 double point mutation of K320A
and K321A, the first PCR reaction amplified the upstream fragment using
the 5' boundary primer (5'-GGAATTCATGGAGGAGCCGCAGTCAGAT-3') and one of the mutant primers (5'-TCCATCCAGTGGTGCCGCCTTTGGCTGGGG-3') readings from
3' to 5'. The second PCR amplified the downstream fragment using mutant
primer (5'-CCCCAGCCAAAGGCGGCACCACTGGATGGA-3') readings from 5' to 3'
and the 3' boundary primer (5'-CCGCTCGAGTCAGTCTGAGTCAGGCCCTTC-3'). These upstream and downstream PCR products, which overlap at the mutation region, were mixed together and used as templates in the last
PCR reaction with 5' and 3' boundary primers. The end PCR product with
the desired mutation was gel-purified and digested with
EcoRI and XhoI before ligation to pAD-GAL4
phagemid vector (Stratagene). Accuracy of these constructs was
confirmed by sequencing.
Yeast Two-hybrid Protein Interaction Assay--
To investigate
interactions between importin Plasmid Construction and Expression of Fusion Proteins--
To
express the normal and the truncated importin Fluorescence Microscopy--
The transfected cells grown on
coverslips were rinsed in PBS solution, fixed for 30 min in 4%
paraformaldehyde in PBS, and air dried. Expression of fusion proteins
was monitored using fluorescence microscopy (Leica DMRBE).
4',6'-Diamidine-2'-phenylindole dihydrochloride (Roche Molecular
Biochemicals) staining was done according to the manufacturer's instructions.
Immunohistochemistry--
Immunohistological staining was
carried out using HistostainTM-plus kit
(Zymed Laboratories Inc.) as described by the
manufacturer. In brief, the transfected cells grown on coverslips were
washed in PBS and fixed for 30 min in 4% paraformaldehyde in PBS with 0.5% Triton X-100. The cells were blocked in PBS containing 10% normal goat serum. The cells were then incubated with anti-p53 antibodies (DO-1 for HBL-100 and ZR-75-1 cells, Pab 246 for CHO-K1; Santa Cruz Biotechnology) for 3 h, followed by three washes with PBS. The biotinylated secondary antibody was reacted with the primary
antibody, followed by three rinses with PBS. Horseradish peroxidase-conjugated streptavidin was then bound to the biotinylated secondary antibody. Antigen-antibody-enzyme complex was visualized by
using AEC chromogen/substrate solution for red signal. Cell staining
was observed by light microscopy (Leica DMRBE).
Northern Blot--
Cellular RNA was isolated from G418-selected
CHO-K1 cells with TRIzol reagent (Life Technologies, Inc.) according to
manufacturer's instructions. For Northern analysis, 10 µg of total
cellular RNA was heat denaturated, separated on 1%
agarose-formaldehyde gels, transferred to Hybond-N+ nylon
membrane and probed with 32P-labeled p21waf1/cip1.
A probe specific for glyceraldehyde-3-phosphate dehydrogenase was used
to confirm equal loading.
Western Blot--
Forty-eight hours after transfection, the
cells were lysed with lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% Triton X-100) containing 0.2 mM
phenylmethylsulfonyl fluoride and 1.0 µg/ml aprotinin and denatured
by boiling in sample buffer for 5 min. After SDS-polyacrylamide gel
electrophoresis, p53 protein was detected in Western blot experiments
using anti-p53 antibody and ECL Western blot reagents (Amersham
Pharmacia Biotech).
Flow Cytometry--
At 24 h post-transfection, adherent and
floating cells were collected, fixed in 2% paraformaldehyde
supplemented with 0.1% Nonidet P-40 and stained with propodium iodide
(Sigma). The cell cycle distribution of each sample was determined by
measuring the DNA content through propidium iodide staining. Samples
were analyzed in a cell sorter (FACSCalibur) using the CellQuest
software (Becton Dickson). The apoptotic fraction was determined by
quantitating the number of cells possessing a sub-G1 DNA
content (22).
Truncated Transcripts of Importin Importin The NLS-mutant p53 Does Not Interact with Importin The Truncated Mutant of Importin p53 Accumulates at the Cytoplasm in the Cells Overexpressing the
Truncated Importin Overexpression of Importin
In addition to the up-regulation of p21waf1/cip1, functional
p53 in nucleus has been shown to transactivate several other genes that could be involved in cell cycle arrest and apoptosis (1, 27). If the
hypothesis that the importin We found a truncated form of importin We found that the breast cancer cell ZR-75-1 shows distinct
immunohistological patterns for p53 localization. Large amounts of p53
were detected in the cytoplasm of the cells (Fig. 1A). RT-PCR analysis demonstrated that the truncated transcript of importin
Although a genomic sequence of importin Sequence analysis showed that a truncated importin Lang and Clarke (33) have reported that both NLSI and two other NLSI
basic domains are concomitantly required for p53 nuclear import. This
means that the NLS1 alone in p53 may not be enough to be bound to the
importin It has been proposed that export of importin Even though the total amount of p53 was not markedly enhanced when
cells were transfected with importin Other tumor suppressor nuclear proteins such as BRCA1 and, most
recently, WT1 have also been observed to be mislocated in the cytoplasm
of breast cancer cells (28). Recently, BRAP2, a novel cytoplasmic
protein that interacts with two functional NLS motifs of BRCA1, has
been reported to retain a newly synthesized BRCA1 protein in the
cytoplasm of breast cancer cells (34). Upon receiving the appropriate
environmental stimulus, BRCA1 is dissociated from BRAP2 and bound to
importin During the period of this work, we have identified similar truncated
importin We thank Drs. J. O. Rimas, Bryan Show,
and W.-H. Lee for valuable advice and comments during the preparation
of this manuscript. We also acknowledge Dr. D. Richardson for his
warmhearted editorial help.
*
This work was supported in part by Korea Research Foundation
Grant 1998-019-F00034.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: 389 Chulsan,
Kwangmyeong, Kyeonggi 423-030, Korea. Tel.: 82-2-6807-164/165; Fax: 82-2-6807-162; E-mail: hjyhdjsj@sungae.co.kr.
Published, JBC Papers in Press, April 28, 2000, DOI 10.1074/jbc.M909256199
2
D.-H. Kim, S.-M. Han, Y.-S. Bae, I.-S. Kim, and
Y-H. Moon, unpublished results.
The abbreviations used are:
NLS(s), nuclear
localization signal(s);
IBB, importin
Truncated Form of Importin
Identified in Breast Cancer Cell
Inhibits Nuclear Import of p53*
, and
Department of Microbiology, Hannam
University, Ojeong-dong 133, Daeduk-gu,
Taejeon 306-791, South Korea
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
. In this report
we demonstrate that importin
binds to NLSI in p53 and mediates the
nuclear import of p53. Reverse transcriptase-polymerase chain reaction
and sequencing analyses showed that a truncated importin
deleted
the region encoding the putative NLS-binding domain of p53, suggesting
that it could not bind to NLSs of p53 proteins. Binding of importin
to p53 was confirmed by using yeast two-hybrid assay. When expressed in
CHO-K1 cells, the truncated importin
predominantly localized to the
cytoplasm. In truncated importin
expressing cells, p53
preferentially localized to cytoplasmic sites as well. A significant
increase in the p21waf1/cip1 mRNA level and induction of
apoptosis were also observed in importin
overexpressing cells.
These results strongly suggest that importin
functions as a
component of the NLS receptor for p53 and mediates nuclear import of p53.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and importin
(6-11). The initial cytoplasmic event in
NLS-dependent nuclear protein import is the binding of the
import cargo to the importin
/
heterodimer. Importin
provides
the NLS-binding site and then interacts via its importin
-binding
domain (IBB domain) with importin
, which in turn interacts with the
nuclear pore complex (10, 12-14). The transfer of the trimeric
NLS-importin
/
complex through the NPC is
energy-dependent and appears to require GTP hydrolysis by
Ran (15).
-mediated
nuclear import of p53. We have newly identified a truncated form of
importin
in a breast cancer cell line. The truncated importin
was tested for its biological activities in line with the nuclear
import of p53.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-specific primers.
RT was performed at 42 °C for 30 min. This was followed by a 2-min
denaturation of DNA at 94 °C and 30 cycles of PCR amplification
using a 30-s 94 °C denaturation step, a 30-s 56 °C annealing step
and a 90-s 72 °C primer extension step. PCR products were resolved
on 1% agarose gel containing 0.5 µg/ml ethidium bromide. To ensure
the PCR products were amplified from importin
transcripts, Southern
blot analysis was performed. PCR products resolved on 1% agarose gel
were transferred to Hybond N+ membrane (Amersham Pharmacia
Biotech) and hybridized with a digoxigenin-11-dUTP-labeled importin
probe. For preparation of the digoxigenin-labeled importin
probe,
pRIP vector (Bioneer) containing the full-length importin
was
digested with PstI and fractionated in 1% agarose gel.
About 0.35-kilobase PstI-digested fragment containing
N-terminal fragment of importin
was isolated, labeled with
digoxigenin-11-dUTP, and used as the probe. The detection of hybridized
DNA was carried out using DNA labeling and detection kit (Roche
Molecular Biochemicals).
and p53, and between importin
and
the NLSI mutant p53, yeast two-hybrid system was used. Yeast strain
YRG-2 (Mat
ura3-52 his3-200 ade2-101 lys2-801 trp1-90
leu2-3 112 gal4-542 gal80-538
LYS2::UASGAL1-TATAGAL1-HIS3 URA3::UASGAL4
17-mers(X3)-TATACYC1-lacZ) was
co-transformed with pBD-I
, pBD-I
NLSb and pAD-p53,
pBD-I
NLSb and pAD-I
, and pBD-I
and pAD-NLSmut p53, and
assayed for
-galactosidase activity as described below. For importin
expression (pBD-I
), a full-length cDNA encoding amino acids
1-529 was fused to the DNA-binding domain of GAL4 in pBD-GAL4 Cam
plasmid (Stratagene). pBD-I
NLSb was constructed by fusing the
truncated importin
to the DNA-binding domain of GAL4 in pBD-GAL4
Cam. pAD-p53 was constructed by fusing p53 to the activation
domain of GAL4 in pAD-GAL4. pAD-I
was constructed by cloning a
partial fragment of importin
(amino acids 331 to 876), covering the
region to interact with importin
, into the activation domain of
GAL4 in pAD-GAL4. To investigate interaction of importin
with NLS
mutant p53, the hybrid proteins were constructed as described above.
Competent cells of yeast strain YRG-2 were prepared by the LiOAc/single
stranded DNA/PEG method (19). Co-transformed cells were plated onto
synthetic dropout medium lacking leucine and tryptophan and
supplemented with 25 mM 3-aminotrizole (Sigma/Aldrich) to
investigate interaction of the hybrid proteins. Interactions of two
partners were confirmed by a 5-bromo-4-chloro-3-indolyl
-D-galactoside filter-staining assay (20). Yeasts
transformed with empty vector alone (pGAL4, Stratagene) or recombinant
plasmid and its corresponding empty vector were used as negative
controls, whereas yeast transformed with pBD-p53 (Stratagene) and
pAD-SV40 (Stratagene) was used as a positive control.
in CHO-K1, we
constructed expression vectors of green fluorescent protein (GFP)-fused
proteins using pEGFP-N1 (CLONTECH). The open
reading frames of the normal and truncated importin
were
translationally fused to GFP in-frame. The coding region of importin
was amplified by using PCR method (primers:
5'-ATGTCCACCAACGAGAATGCTAATAC-3' as upstream primer and
5'-AAAAGTTAAAGGTCCCAG-3' as downstream primer) with Ex
Taq DNA polymerase (Takara) and cloned to SmaI site of pEGFP-N1. The PCR fragment amplified by using PCR method (primers: 5'-ATGTCCACCAACGAGAATGCTAATAC-3' as upstream primer and
5'-CTAAAAGTTAAAGGTCCCAGGAGCCCC-3' as downstream primer) containing the
truncated importin
was digested with HindIII and cloned into the HindIII site in pEGFP-N1. The constructed plasmids
were isolated using the ammonium acetate method (21) and transfected to
CHO-K1 cells as described below. Each 35-mm dish of cells grown to
about 70% confluency was transfected with 2 µg of plasmid DNAs by
using LipofectAMINE (Life Technologies, Inc.). The DNA-liposome complexes were left in the culture medium for 8 h. At that time the medium was drained, and the cells were refed with fresh medium. At
48 h after transfection, the cells were passaged 1:10 into selective medium containing 800 µg/ml G418 and the G418-resistant colonies from each transfection were pooled and expanded into stable
cell lines for Northern blot analysis. To express the normal and
NLSI-mutated p53 in CHO-K1, the normal and the NLSI-mutant p53
generated as described above were ligated to the C terminus of the cyan
fluorescent protein (CFP) in pECFP-C1 vector
(CLONTECH). The constructed plasmids were isolated
with ammonium acetate method (21) and transfected to CHO-K1 as
described above.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Are Observed in Breast Cancer
Cell--
Different from other normal cell lines like HBL-100, a
breast cancer cell ZR-75-1 showed substantial amounts of p53 locating in the cytoplasm (Fig. 1A). In
ZR-75-1 cells, we have newly identified a truncated form of importin
in the experiments of RT-PCR with importin
-specific primers
(Fig. 1B). The mRNA level for the truncated importin
was much higher than that for normal importin
in the cells when
tested by quantitative RT-PCR (data not shown). The truncated cDNA
fragments shown in Fig. 1B were extracted from the gel,
cloned into a vector, and sequenced. Sequencing analysis of the
truncated transcript of importin
showed that the truncated mutant
of importin
was 387 base pairs in size and contained internal
deletion in the cDNA of importin
(Fig. 1C). The
truncated mutant, which we termed I
NLSb, deleted nucleotides from
251 to 1458 and contained an open reading frame encoding 89 amino acids, resulting in premature protein of importin
(Fig.
1C). The truncated transcript I
NLSb contained the IBB
domain whereas a part of the importin
transcript segment encoding
the putative NLS-binding domain was deleted, suggesting that this
deletion mutant would not bind to NLSs of p53 proteins (Fig.
1D).

View larger version (34K):
[in a new window]
Fig. 1.
p53 localization in the breast cancer cell
ZR-75-1 and detection and sequence analysis of truncated importin
. A, immunohistochemistry for p53
localization. ZR-75-1 and HBL-100 cells grown on glass coverslips were
fixed and stained with anti-p53 antibody (DO-1, Santa Cruz Biochem) as
described under "Experimental Procedures." Stained cells were
photographed at X400. B, RT-PCR with RNA prepared from
ZR-75-1 breast cancer cell line and importin
-specific primers. The
amplified DNA fragments were size fractionated on 1% agarose
containing ethidium bromide. B, the cDNA fragment of
truncated importin
in a breast cancer cell line (ZR-75-1) was
cloned to pRIP vector (Bioneer) and sequenced. An arrow
indicates the putative splicing junction in the truncated transcript.
C, nucleotide and putative amino acid sequences of truncated
transcript of importin
. An arrow indicates the putative
splicing junction in the sequence of the truncated transcript.
Asterisk indicates premature stop codon. The putative mature
stop codon is underlined. D, the schematic
diagram of wild-type and the truncated importin
. Each solid
bar represents functional domains in importin
; an Arm repeat
(23), acidic domain (24), IBB domain (10, 12), and NLS-binding domain.
The dashed line represents the deleted portion of the
truncated transcript of importin
. Numbers indicate the
numbers of amino acids in the truncated mutant.
Interacts with p53--
Importin
has been
reported as a mediator for a classical nuclear transport (8). The
nuclear localization signals in the C terminus of the p53 protein are
directly involved in its subcellular localization (16). To be
transported from the cytoplasm to the nucleus, the p53 protein must
bind to a transport mediator through interaction between the
NLS-binding domain of importin
and its NLSs. To investigate whether
importin
interacts with p53, yeast two-hybrid assays were
performed. Interaction between importin
and p53 was detected when
yeast strain YRG-2 was co-transformed with pBD-I
and pAD-p53 and
monitored for leucine and tryptophan prototrophy, and
-galactosidase
activity was measured by filter lift assay (Fig.
2). On the other hand, the truncated
importin
lacking the NLS-binding domain did not interact with p53,
as expected (Fig. 2). When the truncated importin
-expressing
plasmid (pBD-I
NLSb) was co-transfected with importin
-expressing plasmid (pAD-I
) in yeast, the
-galactosidase gene
was normally turned on (Fig. 2). None of the negative controls
(pBD-I
plus pAD, pBD-I
NLSb plus pAD, and pBD-p53 plus pAD)
showed any detectable blue color in filter lift assay. These results
strongly suggest that the truncated region of the importin
is
essential for the p53 binding.

View larger version (23K):
[in a new window]
Fig. 2.
Mutant importin
does not interact with wild-type p53 in yeast two-hybrid
assay. Recombinant yeast cells, transformed with recombinant
plasmids shown in the legend, were plated onto selective medium lacking
leucine and tryptophan, and then tested for
-galactosidase activity
in a filter lift assay with 5-bromo-4-chloro-3-indolyl
-D-galactoside. Combination of p53 and SV40 was used as
positive control.
and Locate
to the Cytoplasm--
In p53, three potential nuclear localization
signals reside in the C terminus of the protein. NLSI (PQPKKKP),
especially, is the key player for the nuclear import of p53 (16). As
expected, importin
would bind to p53 at the NLSI locus. To
investigate whether this NLSI site mediates interaction between
importin
and p53, we have carried out yeast two-hybrid assay with
p53-expressing constructs containing the double mutation at NLSI site
(KK320, 321AA) (Fig. 3A). The
yeast cells were co-transformed with pBD-I
and pAD-NLSwt p53 or
pAD-NLSmut p53, and the colonies showing leucine and tryptophan
prototrophy were subjected to filter lift assay. Importin
did not
interact with the NLS mutant while it did interact with wild-type NLS
showing blue color in the 5-bromo-4-chloro-3-indolyl
-D-galactoside assay (Fig. 3B). NLS mutant
showed blue color when co-transformed with pBD-SV40 (Fig.
3B), suggesting that the NLS mutant p53 was normally
expressed in the transformed yeast. The expression of the NLS mutant
p53 in yeast was also confirmed by Western blot analysis (data not
shown). Because importin
did not interact with the p53 containing
the double mutations (K320A/K321A) at NLSI site, the NLS mutant p53
might be sequestered in the cytoplasm. To test this hypothesis, we
constructed an NLS mutant p53/CFP fusion protein containing KK320,
321AA in the putative p53 NLS (Fig. 3A). When CHO-K1 cells
were transfected with p53-expressing plasmid, the NLS mutant p53 were
located only to the cytoplasm (Fig. 3C, lower panel), while
NLS wild-type p53 located to the nucleus (Fig. 3C, upper
panel). These results suggest that the NLS mutant p53 does not
bind to importin
and thus results in sequestration of p53 in the
cytoplasm, and supports that the nuclear import of p53 is mediated by
importin
.

View larger version (62K):
[in a new window]
Fig. 3.
Interaction of importin
with the NLS mutant p53 and the subcellular localization of the
p53 mutant. A, the schematic diagram of the expression
plasmids for wild-type and NLS mutant p53. The amino acids of the major
nuclear localization signal of wild-type p53 and the NLS mutant p53 are
given in a single-letter symbol. Substitution of these amino
acids was conducted as described under "Experimental Procedures."
The wild-type and NLS mutant p53 were ligated to the C terminus of the
CFP in pECFP-C1 vector (CLONTECH). B,
interactions between the NLS mutant p53 and importin
were tested by
yeast two-hybrid and filter lift assay as described previously. Each
spot shows the signal of the recombinant yeast co-transformed with
pBD-I
+ pAD-p53 and pBD-I
+ pAD-NLSmut p53. C, the
subcellular localization of the NLS1 mutant p53. CHO-K1 cells were
cultured on glass coverslips and transfected with the CFP-fused
expression plasmids, pNLSwt p53/CFP, and pNLSmut p53/CFP. After 24 h, the cells were fixed in paraformaldehyde, and examined with a
fluorescent microscope. The NLSmut p53/CFP fusion protein was only
observed in the cytoplasm of CHO-K1 cell (d) while the NLSwt
p53/CFP fusion protein was preferentially observed in the nucleus
(a). 4',6'-Diamidine-2'-phenylindole dihydrochloride (DAPI)
staining is shown in b and e to indicate nuclei
of the cells, and c and f are the corresponding
phase-contrast images.
Is Preferentially Located to
the Cytoplasm--
Importin
is only known as a cargo receptor and
importin
thus must first bind to importin
-binding domain of
importin
for its nuclear translocation (8). It is also known that only the IBB domain could transport the fusion protein to the nucleus
(10, 25). Notably, although the I
NLSb mutant deleted the region
encoding the NLS-binding domain, it contained the IBB domain. To
investigate whether the truncated importin
is functional in nuclear
localization, expression vectors for fusion proteins in which the open
reading frames of wild-type importin
and the truncated-type
importin
were fused with that of GFP and were constructed and
termed pI
/GFP and pI
NLSb/GFP, respectively. Using this method,
the localization in cells of the fused proteins could be easily
monitored by fluorescence microscopy. When expressed in CHO-K1 cell,
the I
NLSb/GFP fusion protein was preferentially observed in the
cytoplasm and accumulated at the cytoplasmic periphery of the nuclear
envelope (Fig. 4, g and
h) while control GFP protein was in both the nucleus and the
cytoplasm (Fig. 4, a and b). In contrast, the
I
/GFP fusion protein was preferentially observed in the nucleus
(Fig. 4, d and e). The same result was obtained when the fusion proteins were expressed in HBL-100 and 293 cells (data
not shown)). These data strongly suggest that truncated importin
is
not functional for nuclear localization even though it contains intact
IBB domain.

View larger version (135K):
[in a new window]
Fig. 4.
The subcellular localization of the truncated
importin
. CHO-K1 cells were cultured on
glass coverslips and transfected with the GFP-fused expression
plasmids, pI
/GFP and pI
NLSb/GFP for the wild-type and
mutant-importin
cDNA, respectively. After 24 h, the cells
were fixed in paraformaldehyde, and examined with a fluorescent
microscope. GFP-fused mutant p53 was preferentially observed in the
cytoplasm and accumulated at the cytoplasmic periphery of the nuclear
envelope (g and h) while control GFP protein was
in both nucleus and cytoplasm (a and b). In
contrast, GFP-fused importin
was preferentially observed in the
nucleus (d and e). 4',6'-Diamidine-2'-phenylindole dihydrochloride
staining is shown in b, e, and h to indicate
nuclei of the cells. Panels c, f, and i indicate
the phase-contrast images.
--
Different from other cell lines, ZR-75-1
cells were nicely stained by anti-p53 antibody at the cytoplasm as well
as the nucleus in the experiments of immunohistochemical staining (Fig.
1A). Our accumulative results, showing that importin
binds to p53 protein, the truncated importin
loses its binding
capacity to p53, and the truncated importin
is localized
predominantly to the cytoplasm of CHO-K1 cells expressing the truncated
importin
-GFP fusion protein, led us to assume that the p53
enhancement in the cytoplasm of ZR-75-1 is likely to be associated with
the expression of truncated importin
. We have examined the p53
localization in the mutant I
-expressing CHO-K1 cells. The expression
of the truncated importin
and the location of p53 proteins were
monitored by GFP fluorescence and immunohistochemical staining with a
monoclonal anti-p53 antibody, respectively. As shown in Fig.
5, p53 was accumulated at the cytoplasm
in truncated importin
-expressing CHO-K1 cells (Fig. 5B)
while preferentially localized to the nuclei in normal importin
-expressing CHO-K1 cells (Fig. 5A). These results,
together with our previous results, strongly suggest that the p53
accumulation at the cytoplasm rather than efficient localization to the
nucleus in the ZR-75-1 cells is, at least in part, due to the existence of dysfunctional importin
in the breast cancer cells.

View larger version (60K):
[in a new window]
Fig. 5.
Overexpression of truncated importin
changes subcellular localization of wild-type
p53. CHO-K1 cells grown on glass coverslip were transfected with
pI
/GFP (A) and pI
NLSb/GFP plasmids (B),
respectively. After 48 h, the cells were fixed in neutral
paraformaldehyde. The coverslips were incubated with anti-p53 antibody
(Pab 246, Santa Cruz Biotechnology) and stained with a
HistostainTM plus kit for detection, and then
examined with a light microscope (Leica DMRBE). In CHO-K1 cells
expressing the truncated importin
, p53 predominantly localized to
the cytoplasm (B), while it localized to the nucleus in
wild-type importin
expressing cells (A).
Induces p53-mediated Biological
Activity--
Biologically active p53 in nucleus modulates the
transcription of its downstream target genes, such as bax,
p21, GADD45, etc, resulting in growth
arrest or apoptosis (1). To see whether the importin
-mediated
nuclear-imported p53 shown in Fig. 5 is functional or not, we examined
the expression level of the p21waf1/cip1 gene, which is
considered to be the most important p53-responsive gene (26), by
Northern blot analysis in importin
-overexpressing CHO-K1 cells. A
significant increase in waf1/cip1 mRNA level was observed in CHO-K1 cells transfected with pI
/GFP plasmid, but not in
GFP-transfected control cells nor in pI
NLSb/GFP-transfected CHO-K1 cells (Fig. 6A). Total
protein level of p53 was slightly increased in the cells transfected
with pI
/GFP plasmid (Fig. 6B).

View larger version (38K):
[in a new window]
Fig. 6.
Overexpression of importin
induces p21waf1/cip1 expression and
apoptosis. A, Nothern blot hybridization of
p21waf1/cip1 mRNA expressed in the CHO-K1 cells transfected
with wild-type and truncated importin
. Total RNA was purified from
the transfected cells, separated on denaturing agarose gel
electrophoresis, and then Northern blot hybridized with
32P-labeled human p21waf1/cip1 probe. The
upper panel shows Nothern signals for p21waf1/cip1
message and the lower panel shows subsequent hybridization
with a glyceraldehyde-3-phosphate dehydrogenase probe for normalization
of each RNA sample. B, quantitation of p53 in Western blot
analysis. Immunoblot signals display the amounts of p53 expressed in
CHO-K1 cells without transfection (lane 1) or transfected
with pGFP (lane 2), pI
/GFP (lane 3), and
pI
NLSb/GFP (lane 4). Actin was used for normalization of
each sample. C, DNA content profiles. CHO-K1 cells were
transfected with the indicated plasmids and then subjected to flow
cytometric DNA content analysis. Cells were fixed and stained with
propodium iodide. Cells with sub-G1 DNA content were taken
to be apoptotic. Percentages of the cells with sub-G1 DNA
content are indicated below the corresponding plasmids.
facilitate the nuclear import of p53
is true, overexpression of importin
may cause cell growth arrest
and apoptosis by enhancement of nuclear import of p53 and transactivation of p53-responsive apoptotic factors. CHO-K1 cells were
transfected with the expression plasmids, pGFP, pI
/GFP, pI
NLSb/GFP, and pp53. Forty-eight hours post-transfection, cells were harvested, stained with propodium iodide, and subjected to flow-cytometric analysis. Cells with DNA content less than 2 N (sub-G1 in Fig. 6C) are considered
apoptotic (28). As shown in Fig. 6C, wild-type p53- and
importin
-transfected cells induced apoptosis by 17 and 24%,
respectively, whereas GFP- transfected cells and truncated importin
-transfected cells induced only by 4 and 6%, respectively. These
experimental results strongly suggest that importin
mediates the
nuclear import of p53, followed by transactivation of p53-responsive
genes in nucleus and induction of consecutive p53-mediated biological activities.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
in the breast cancer
cell ZR-75-1 in which substantial amounts of p53 were localized in the
cytoplasm (Fig. 1A). The truncated importin
has a
deletion in the middle of the RNA transcript (Fig. 1C). The
deleted region covers the putative p53 NLS-binding domain (Fig.
1D). As expected, this deletion mutant could not bind to the
wild-type p53 protein (Fig. 2). Yeast two-hybrid assay showed that
normal importin
interacts with p53 (Fig. 2), while the NLS1 mutant
p53 does not bind to importin
(Fig. 3B), suggesting that
the NLS1 of the p53 is an important binding site to importin
. The
NLS mutant p53 was also sequestered in the cytoplasm (Fig.
3C). When expressed in CHO-K1 cells, the GFP-fused truncated
mutant of importin
preferentially localized to the cytoplasm (Fig.
4). In truncated importin
-expressing cells, p53 predominantly
localized to the cytoplasm (Fig. 5B). Particularly
noteworthy is that a significant increase in p21waf1/cip1
mRNA level and enhancement of apoptosis were observed in the wild-type importin
-overexpressing cells (Fig. 6), suggesting that
p53 is efficiently transported to the nucleus through the importin
-mediated nuclear transport system. Based on our present results, we
address that the cytoplasmic sequestration of p53 in the breast cancer
cell ZR-75-1 is likely to be associated with the presence of truncated
importin
lacking in the NLS-binding domain, and is thus inefficient
to transport p53 to the nucleus.
exists in a cell line ZR-75-1 (Fig. 1B). Generally, ZR-75-1 cells show predominant mRNA level for truncated importin
as compared with that for normal importin
as shown in Fig. 1B and in repeated quantitative RT-PCRs (data not shown). At
times, however, the expression amount of mutant mRNA was not so
much enhanced as usual. The fluctuation of mutant mRNA level is
thought to be associated with the cell growth rate and culture conditions.
has not yet been
identified, sequence analysis of the RNA transcripts at the junction of
the deleted sequence suggested that these truncated transcripts might
be generated by the aberrant RNA splicing. The truncated transcript of
importin
containing AAG at the end of 5' exon sequence and G/A at
the 3' exon sequence (Fig. 1) match the canonical consensus sequences
of the upstream and downstream splice donor and acceptor sites. It has
been shown that the truncated transcripts of tumor suppressor genes,
such as WT1, BRCA1, and TSG101, are frequently found in breast cancer (29-31). Although importin
is
unlikely to act as a direct tumor suppressor, alternation of its
phenotype may have influence on the functions of other important tumor
suppressors that should be transported to the nucleus to be
functionally active. With this regard, we have characterized the
truncated importin
, which may provide many important insights into
the tumorigenesis of the breast cancer.
contains the IBB
domain but lacks NLS-binding domain. It has been reported that importin
binds to the IBB domain of importin
and transports it into the
nucleus (10). In our present study, however, the truncated importin
containing the IBB domain was preferentially detected at the cytoplasm
rather than in the nucleus of both CHO-K1 (Fig. 4) and HBL-100 cells
(data not shown). The truncated importin
was confirmed still to
have a binding capacity to importin
(Fig. 2) as reported previously
in the experiment with other deletion mutants of importin
(23).
Whereas, normal importin
was detected predominantly in the nucleus
in the same condition. These results suggest that the IBB domain may
not be enough for the importin
-mediated translocation of importin
into the nucleus.
, resulting in a defect for nuclear localization of p53. In
our experiments, however, NLS1 mutant p53 completely lost its binding
capacity to importin
(Fig. 3), while K305A mutant p53 did not, and
the nuclear localization of the K305A mutant was as efficient as that
of wild-type p53 (data not shown). Although we did not perform the
quantitative analysis of the binding affinity between importin
and
each NLS of p53, our experimental results suggest that the NLS1 of p53
would be much more essential than other NLSs for importin
-binding
and nuclear import of p53. Precise interaction mechanisms remain to be discovered.
into cytoplasm is
mediated by the Crm1 nuclear export protein which would interact with a
leucine-rich nuclear export signal located between residues 207 and 217 in Arm repeat 3 of importin
(17, 32). On the other hand, it has
also been proposed that export of importin
is dependent on the
distinct nuclear export factor, CAS, which is another member of the
importin
family and interacts with an unmapped nuclear export
signal located near the C terminus of importin
(23). Although the
precise mechanism of the importin
export into the cytoplasm is
still unclear, it is generally accepted that importin
in the
nucleus should be transported to the cytoplasm where it could be
recharged with cargoes and re-transported by importin
. When
expressed by transfection with pI
/GFP plasmid, however, the fusion
protein I
/GFP was preferentially localized to the nuclei of CHO-K1
(Fig. 4) and HBL-100 cells (data not shown). We assume that the GFP
fusion to the importin
at the C terminus may inhibit the binding of
nuclear export factor to importin
by masking or changing the
conformation of the essential CAS/Crm1-binding domain in importin
.
-expression plasmid (Fig.
6B), p53 was efficiently localized to the nucleus (Fig. 5),
suggesting that the enhancement of importin
expression may facilitate the nuclear localization of p53, resulting in the induction of p53-mediated biological activities, such as growth arrest or apoptosis (Fig. 6C). Nevertheless, we cannot exclude
nonspecific or other secondary effects that may lead to p21
up-regulation and apoptosis, for importin
is not an exclusive
import factor for p53. Also, our illustration does not exclude the
possibilities of plethoric effects of importin
-overexpression,
which may cause apoptosis through other unrevealed mechanisms rather
than p53-mediated apoptotic procedures.
for moving into the nucleus. Besides, importin
has the
intriguing features of the armadillo family proteins that can be
attached to the cytoskeleton through the interaction of nuclear
regulatory proteins anchored to the cytoskeleton (35).
NLS-dependent association of importin
with the
cytoskeleton would be important for anchoring the NLS receptor in the
cytoplasm, revealing that importin
could serve as both an anchor
and a carrier protein of nuclear regulatory proteins. These data
suggest that a certain defect or phenotypic changes of transport
factors may cause mislocation of tumor suppressor proteins, leading to
inactivation of their tumor suppressor functions. With this regard, we
are assuming two possible mechanisms for the truncated importin
mutant-mediated inhibition of p53 nuclear import in breast cancer: (i)
overexpression of mutant importin
may cause a feedback inhibition
of functional importin
expression, resulting in the inhibition
of p53 nuclear import, or (ii) even though the wild-type and
mutant importin
have a similar binding capacity to importin
,
the relative amounts of importin
available for this binding may not
be enough to cover the mutant and wild-type importin
, thus
functional importin
has only a little chance to bind importin
,
resulting in inefficient translocation of p53 into the nucleus.
mutants lacking NLS-binding domain from several breast
cancer cells and tumor
tissues.2 Although there are
still many questions remaining unanswered for its detail mechanisms,
considering the report that mere reduction in p53 levels is sufficient
to promote tumorigenesis (36), the truncated importin
is likely to
be involved in the tumorigenesis or tumor progression of breast cancer
and other tumors by causing inefficient nuclear import of functional
p53 and/or other tumor suppressor nuclear proteins. Further intensive
studies are required to reveal the precise biological role of truncate
importin
in the breast cancer and other tumors.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
binding;
PBS, phosphate-buffered saline;
GFP, green fluorescent protein;
CFP, cyan
fluorescence protein;
RT-PCR, reverse transcriptase-polymerase chain
reaction;
CHO, Chinese hamster ovary.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Ko, L. J.,
and Prives, C.
(1996)
Genes Dev.
10,
1054-1072
2.
Moll, U. M.,
Riou, G.,
and Levine, A. J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
7262-7266
3.
Moll, J. M.,
Laquaglia, M.,
Benard, J.,
and Riou, G.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4407-4411
4.
Bosari, S.,
Viale, G.,
Roncalli, M.,
Graziani, D.,
Borsani, G.,
Lee, A. K.,
and Coggi, G.
(1995)
Am. J. Pathol.
147,
790-798
5.
Liang, X. H.,
Volkmann, M.,
Klein, R.,
Herman, B.,
and Lockett, S. J.
(1993)
Oncogene
8,
2645-2652
6.
Görlich, D.,
Vogel, F.,
Mills, A. D.,
Hartmann, E.,
and Laskey, R. A.
(1995)
Nature
377,
246-248
7.
Nigg, E. A.
(1997)
Nature
386,
779-787
8.
Görlich, D.
(1998)
EMBO J.
17,
2721-2727
9.
Görlich, D.,
and Mattaj, I. W.
(1996)
Science
271,
1513-1518
10.
Weis. K., Ryder, U., and Lamond, A. L. (1996) EMBO J. 1818-1825
11.
Mattaj, I. W.,
and Englmeier, L.
(1998)
Annu. Rev. Biochem.
67,
265-306
12.
Kutay, U.,
Izaurralde, E.,
Bischoff, F. R.,
Mattaj, I. W.,
and Görlich, D.
(1997)
EMBO J.
16,
1153-1163
13.
Radu, A.,
Blobel, G.,
and Moore, M. S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1769-1773
14.
Kraemer, D. M.,
Strambio-de-Castillia, C.,
Blobel, G.,
and Rout, M. P.
(1995)
J. Biol. Chem.
270,
19017-19021
15.
Moore, M. S.
(1998)
J. Biol. Chem.
273,
22857-22860
16.
Dang, C. V.,
and Lee, W. M.
(1989)
J. Biol. Chem.
264,
18019-18023
17.
Stommel, J. M.,
Marchenko, N. D.,
Jimenez, G. S.,
Moll, U. M.,
Hope, T. J.,
and Wahl, G. M.
(1999)
EMBO J.
18,
1660-1672
18.
Horton, R.,
Cai, Z.,
Ho, S.,
and Pease, L.
(1990)
BioTechniques
8,
528-531
19.
Gietz, R. D.,
and Schiestl, R. H.
(1995)
Methods Mol. Cell. Biol.
5,
255-269
20.
Bartel, P.,
and Field, S.
(1995)
Methods Enzymol.
254,
241-263
21.
Saporito-Irwin, S. M.,
Geist, R. T.,
and Gutmann, D. H.
(1997)
BioTechniques
23,
424-427
22.
Haupt, Y.,
Barak, Y.,
and Oren, M.
(1996)
EMBO J.
15,
1596-1606
23.
Herold, A.,
Truant, R.,
Wiegand, H.,
and Cullen, B. R.
(1998)
J. Cell Biol.
143,
309-318
24.
Monteiro, A. N. A.,
August, A.,
and Hanafusa, H.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13595-13599
25.
Görlich, D.,
Henklein, P.,
Laskey, R. A.,
and Hartmann, E. A.
(1996)
EMBO J.
15,
1810-1817
26.
El-Deiry, W. S.,
Tokino, T.,
Velculescu, V. E.,
Levy, D. B.,
Parson, R.,
Trent, J. M.,
Lin, D.,
Mercer, W. E.,
Kinzler, K. W.,
and Vogelstein, B.
(1993)
Cell
75,
817-825
27.
Hirao, A.,
Kong, Y. Y.,
Matsuoka, S.,
Wakeham, A.,
Ruland, J.,
Yoshida, H.,
Liu, D.,
Elledge, S. J.,
and Mak, T. W.
(2000)
Science
287,
1824-1827
28.
Darzynkiewicz, Z.,
Bruno, S.,
Del, Bino, G.,
Gorczyca, W.,
Hotz, M. A.,
Lassota, P.,
and Traganos, F.
(1992)
Cytometry
13,
795-808
29.
Silberstein, G. B.,
Horn, K. V.,
Strickland, P.,
Roberts, C. T., Jr.,
and Daniel, C. W.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8132-8137
30.
Lu, M.,
Conzen, S. D.,
Cole, C. N.,
and Arrick, B. A.
(1996)
Cancer Res.
56,
4578-4581
31.
Lee, M. P.,
and Feinberg, A. P.
(1997)
Cancer Res.
57,
3131-3134
32.
Boche, I.,
and Fanning, E.
(1997)
J. Cell Biol.
139,
313-325
33.
Lang, S-H.,
and Clarke, M. F.
(1999)
J. Biol. Chem.
274,
32699-32703
34.
Li, S.,
Ku, C-Y.,
Farmer, A. A.,
Cong, Y-S.,
Chen, C-F.,
and Lee, W-H.
(1998)
J. Biol. Chem.
273,
6183-6189
35.
Smith, H. M.,
and Raikhel, N. V.
(1998)
Plant Cell
10,
1791-1799
36.
Sundaresan, V.,
Shi, Y-P.,
Jones, S. N.,
Vogel, H.,
Bradley, A.,
Pinkel, D.,
and Donehower, A. D.
(1998)
EMBO J.
17,
4657-4667
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Kaku, K.-i. Matsuda, A. Tsujimura, and M. Kawata Characterization of Nuclear Import of the Domain-Specific Androgen Receptor in Association with the Importin {alpha}/{beta} and Ran-Guanosine 5'-Triphosphate Systems Endocrinology, August 1, 2008; 149(8): 3960 - 3969. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bottger, E. Jerszyk, B. Low, and C. Walker Genotoxic Stress-Induced Expression of p53 and Apoptosis in Leukemic Clam Hemocytes with Cytoplasmically Sequestered p53 Cancer Res., February 1, 2008; 68(3): 777 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Wang, Y.-G. Tsay, B. C.-M. Tan, W.-Y. Lo, and S.-C. Lee Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305 J. Biol. Chem., July 3, 2003; 278(28): 25568 - 25576. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Quadrini and J. J. Bieker Kruppel-like Zinc Fingers Bind to Nuclear Import Proteins and Are Required for Efficient Nuclear Localization of Erythroid Kruppel-like Factor J. Biol. Chem., August 23, 2002; 277(35): 32243 - 32252. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ahn, Y. Lee, C. Jeon, S.-J. Lee, B.-H. Lee, K. D. Choi, and Y.-S. Bae Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis Blood, August 13, 2002; 100(5): 1742 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-G. Lee, D.-Y. Kim, B.-H. Hyun, and Y.-S. Bae Novel Design Architect |